# US 2025/0059600 A1 · Mass based detection of pcr amplicons

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0059600 A1
- Document ID: US20250059600A1
- Status: Published application
- Kind: A1
- Application number: 18/717,650
- Filed: 2022-12-06
- Published: 2025-02-20
- Earliest claimed: 2021-12-09
- Assignees: Roche Molecular Systems, Inc.
- Applicants: Roche Molecular Systems, Inc.
- Inventors: Laura M. Jung
- Web page: https://patentgrep.com/patent/US20250059600A1

## CPC

- C12Q 1/6823: Release of bound markers
- C12Q 1/6872: involving mass spectrometry
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present invention provides for novel methods and compositions for nucleic acid sequence detection. Unique, identifying positively charged tags from oligonucleotide probes, bound to target nucleic acids, are produced during PCR by the 5′-nuclease activity of the polymerase. The identity of the targets can be determined by identifying the unique positively charged tags.

## Claims

### Claim 1

A method of detecting the presence or absence of a target nucleic acid sequence in a sample, comprising the steps of:
(a) contacting a sample comprising a target nucleic acid with
(i) a pair of oligonucleotide primers comprising a first oligonucleotide primer and a second oligonucleotide primer, wherein the first oligonucleotide primer comprises a sequence complementary to a region in one strand of the target nucleic acid sequence and is capable of priming the synthesis of a first extension product, and wherein the second oligonucleotide primer comprises a sequence complementary to a region in said first extension product and is capable of priming the synthesis of a nucleic acid strand complementary to said first extension product, and
(ii) an oligonucleotide probe comprising a Positive Ion Reporter Tag (PIRT) at the 5′-terminus, whereby the PIRT is protonated under acidic conditions;
(b) amplifying said target nucleic acid sequence with a nucleic acid polymerase having 5′ to 3′ nuclease activity under conditions that allow annealing of said pair of oligonucleotide primers and said oligonucleotide probe to the target nucleic acid sequence and synthesis of primer extension products from said pair of oligonucleotide primers, while the 5′ to 3′ nuclease activity of said nucleic acid polymerase is able to cleave and release from the annealed oligonucleotide probe fragments containing the PIRT with or without additional nucleotides from the oligonucleotide probe; and
(c) detecting the presence or absence of the PIRT by an electrospray ionization liquid chromatography mass spectrometer (ESI-LCMS) under acidic conditions, thereby detecting the presence or absence of the target nucleic acid sequence in the sample;

### Claim 2 (depends on 1)

The method of claim 1, wherein two or more target nucleic acids are detected in a single multiplexed reaction.

### Claim 3 (depends on 2)

The method of claim 2, wherein two or more oligonucleotide probes are used to detect the two or more target nucleic acids in the single multiplexed reaction.

### Claim 4 (depends on 1)

The method of claim 1, wherein the amplifying step is a polymerase chain reaction (PCR) or a real-time polymerase chain reaction (RT-PCR).

### Claim 5 (depends on 1)

The method of claim 1, wherein the detecting step (c) is done by a mass spectrometer, selected from Electrospray Ionization-Time of Flight Mass Spectrometer (ESI-TOF-MS) or Electrospray Ionization-Liquid Chromatography Mass Spectrometer (ESI-LC-MS).

### Claim 6 (depends on 1)

The method of claim 1, wherein the nucleic acid polymerase is a thermostable DNA polymerase.

### Claim 7 (depends on 1)

The method of claim 1, wherein the PIRT comprises a positive ion entity selected from C6-amino dT, C6-amino, and C12-amino.

### Claim 8 (depends on 7)

The method of claim 7, wherein the PIRT further comprises spacer moieties selected from C3 Spacer, C9 Spacer, C18 Spacer, d Spacer and combinations of the spacer moieties thereof.

### Claim 9

A composition comprising an oligonucleotide probe, wherein said oligonucleotide probe comprises a Positive Ion Reporter Tag (PIRT) at the 5′-terminus, wherein the PIRT is protonated under acidic conditions.

### Claim 10 (depends on 9)

The composition of claim 9, wherein the PIRT comprises a positive ion entity selected from C6-amino dT, C6-amino, and C12-amino.

### Claim 11 (depends on 10)

The composition of claim 10, wherein the PIRT further comprises spacer moieties selected from C3 Spacer, C9 Spacer, C18 Spacer, d Spacer, and combinations of the spacer moieties thereof.

### Claim 12 (depends on 1)

The method of claim 1, wherein no post-amplification sample purification step is performed between step (b) and step (c).

### Claim 13

A method of detecting the presence or absence of at least two target nucleic acid sequences in a sample, comprising the steps of:
(a) contacting a sample comprising at least a first target nucleic acid and a second target nucleic acid with
(i) a first pair of oligonucleotide primers corresponding to the first target nucleic acid, the first pair of primers comprising a first oligonucleotide primer and a second oligonucleotide primer, wherein the first oligonucleotide primer comprises a sequence complementary to a region in one strand of the first target nucleic acid sequence and is capable of priming the synthesis of a first extension product, and wherein the second oligonucleotide primer comprises a sequence complementary to a region in the first extension product and is capable of priming the synthesis of a nucleic acid strand complementary to the first extension product,
(ii) a second pair of oligonucleotide primers corresponding to the second target nucleic acid, the second pair of primers comprising a third oligonucleotide primer and a fourth oligonucleotide primer, wherein the third oligonucleotide primer comprises a sequence complementary to a region in one strand of the second target nucleic acid sequence and is capable of priming the synthesis of a second extension product, and wherein the fourth oligonucleotide primer comprises a sequence complementary to a region in the second extension product and is capable of priming the synthesis of a nucleic acid strand complementary to the second extension product, and
(iii) a first oligonucleotide probe comprising a first Positive Ion Reporter Tag (PIRT) at the 5′-terminus, and a second oligonucleotide probe comprising a second PIRT at the 5′-terminus, whereby the first and second PIRT are each protonated under acidic conditions;
(b) amplifying the first and second target nucleic acid sequences with a nucleic acid polymerase having 5′ to 3′ nuclease activity under conditions that allow
(i) annealing of the first pair of oligonucleotide primers and the first oligonucleotide probe to the first target nucleic acid sequence and synthesis of primer extension products from the first pair of oligonucleotide primers, and
(ii) annealing of the second pair of oligonucleotide primers and the second oligonucleotide probe to the second target nucleic acid sequence and synthesis of primer extension products from the second pair of oligonucleotide primers,
wherein the 5′ to 3′ nuclease activity of the nucleic acid polymerase is able to cleave and release from the annealed first and second oligonucleotide probe fragments containing the first and second PIRT with or without additional nucleotides from the oligonucleotide probe; and
(c) detecting the presence or absence of the first and second PIRT by an electrospray ionization liquid chromatography mass spectrometer (ESI-LCMS) under acidic conditions, thereby detecting the presence or absence of the first and second target nucleic acid sequences in the sample.

### Claim 14 (depends on 13)

The method of claim 13, wherein no post-amplification sample purification step is performed between step (b) and step (c).

### Claim 15 (depends on 13)

The method of claim 13, wherein the first and second PIRT each comprise a positive ion entity selected from C6-amino dT, C6-amino, and C12-amino.

### Claim 16 (depends on 15)

The method of claim 15, wherein the first and second PIRT each further comprise spacer moieties selected from C3 Spacer, C9 Spacer, C18 Spacer, d Spacer and combinations of the spacer moieties thereof.
